Literature DB >> 8360735

Evaluation of pressure changes in feeding arteries during embolization of intracerebral arteriovenous malformations.

T Handa1, M Negoro, S Miyachi, K Sugita.   

Abstract

The pressure in 47 arteries feeding 21 arteriovenous malformations (AVM's) was investigated during transarterial embolization using a Tracker-18 microcatheter. On average, systolic pressure increased by 22 mm Hg. In AVM's with single or few feeders, embolization was usually achieved well; in contrast, giant AVM's with multiple feeders and a large arteriovenous shunt were poorly embolized. However, large AVM's with well-demarcated components may be reduced by embolization to an appropriate size for surgery or stereotactic radiation therapy. It was found that the feeding artery pressure increased significantly more in well-embolized than in poorly embolized cases. Measurements of the feeding artery pressure clarified the hemodynamics of AVM's and facilitated more successful embolization.

Entities:  

Mesh:

Year:  1993        PMID: 8360735     DOI: 10.3171/jns.1993.79.3.0383

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Endovascular Pressure Measurements: Validation with a Pulsatile Flow Model and Haemodynamic Assessment of Brain AVMs.

Authors:  M Forjaz Secca; P Vilela; J L Ferreira; F C Lopes; A Goulão
Journal:  Interv Neuroradiol       Date:  2005-02-08       Impact factor: 1.610

2.  Treatment of cerebral arteriovenous malformations by neuroradiological intervention and surgical resection.

Authors:  M Westphal; L Cristante; U Grzyska; N Freckmann; F Zanella; H Zeumer; H D Herrmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Complication analysis of 469 brain arteriovenous malformations treated with N-butyl cyanoacrylate.

Authors:  T L Li; B Fang; X Y He; C Z Duan; Q J Wang; Q P Zhao; Q Yi Fm Huan
Journal:  Interv Neuroradiol       Date:  2005-10-25       Impact factor: 1.610

4.  Can induction of systemic hypotension help prevent nidus rupture complicating arteriovenous malformation embolization?: analysis of underlying mechanism achieved using a theoretical model.

Authors:  T F Massoud; G J Hademenos; W L Young; E Gao; J Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

5.  Electrical models in the analysis of hemodynamic characteristics of arteriovenous malformations. Part 1: baseline measurements.

Authors:  G Guglielmi
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

6.  Acute rupture of a feeding artery aneurysm after embolization of a brain arteriovenous malformation.

Authors:  Matthew R Reynolds; Eric J Arias; Arindam R Chatterjee; Michael R Chicoine; Dewitte T Cross
Journal:  Interv Neuroradiol       Date:  2015-06-30       Impact factor: 1.610

7.  Predictors of hemorrhagic complications from endovascular treatment of cerebral arteriovenous malformations.

Authors:  José A Jordan; Juan Carlos Llibre; Frank Vázquez; Raúl Rodríguez; José A Prince; José Carlos Ugarte
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

8.  Bleeding complications after endovascular therapy of cerebral arteriovenous malformations.

Authors:  J O Heidenreich; S Hartlieb; R Stendel; T A Pietilä; P Schlattmann; K-J Wolf; A M Schilling
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

9.  Pressure measurements in arterial feeders of brain arteriovenous malformations before and after endovascular embolization.

Authors:  H Henkes; T F Gotwald; S Brew; F Kaemmerer; E Miloslavski; D Kuehne
Journal:  Neuroradiology       Date:  2004-06-15       Impact factor: 2.804

10.  Single-Stage Combined Embolization and Resection for Spetzler-Martin Grade III/IV/V Arteriovenous Malformations: A Single-Center Experience and Literature Review.

Authors:  Yu Chen; Ruinan Li; Li Ma; Yang Zhao; Tengfei Yu; Hao Wang; Xun Ye; Rong Wang; Xiaolin Chen; Yuanli Zhao
Journal:  Front Neurol       Date:  2020-10-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.